Download
1 / 3
30 likes | 37 Views
Japan Gravesu2019 disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the countryu2019s population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Graveu2019s disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in Japan. Thus, the prevalence of disease is likely to propel the Japan Gravesu2019 disease market growth during the forecast period.
E N D
Orion Market Research Japan Graves’ disease Market Size, Segmentation, Share, Forecast, Analysis, Industry Report to 2025 Request a Free Sample of our Report on Japan Graves’ disease Market @ https://www.omrglobal.com/request-sample/japan-graves-disease-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404
Japan Graves’ disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country’s population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave’s disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in Japan. Thus, the prevalence of disease is likely to propel the Japan Graves’ disease market growth during the forecast period. Request a Free Sample of our Report on Japan Graves’ disease Market @ https://www.omrglobal.com/request-sample/japan-graves-disease-market Further, the two regulatory agencies responsible for the Grave’s disease treatment products and services in Japan, includes, Ministry of Health Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) which are responsible for the laws and regulation for medical devices & drugs and quality of pharmaceuticals and medical devices respectively. According to the National Centre for Biotechnology Information (NCBI), in 2017, a range of childhood hyperthyroidism cases are accredited under Grave’s disease. Moreover, pediatric patients consist of less than 5% of the total number of patients that are suffering from Grave’s disease, wherein the prevalence rate of the disease in children and adolescents is around 0.02%. In Japan, around 40% of children have a familial history of the Graves’ disease, with frequency rate of 2% to 3%. A https://www.omrglobal.com/industry-reports/japan-graves-disease-market full Report of Japan Graves’ disease Market is Available at: Japan Graves’DiseaseMarket Segmentation By Diagnosis •Ultrasound •Imaging Tests •Radioactive Iodine Uptake •Blood Sample
By Treatment •Anti- Thyroid Medication •Radioactive Iodine Therapy •Surgery Company Profiles •Abbott Laboratories Inc. •Allergan PLC •Eli Lilly and Co. •GlaxoSmithKline PLC •Johnson & Johnson •Macleods Pharmaceuticals Ltd. •Merck & Co. Inc. •Mylan NV •Novartis International AG •Pfizer Inc. For https://www.omrglobal.com/report-customization/japan-graves-disease-market More Customized Data, Request for Report Customization @ About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404
